* Says it has earned a milestone for the dosing of a first
patient in a clinical trial by its alliance partner,
Bristol-Myers Squibb Company (BMS)
The post BRIEF-PeptiDream achieves milestone for initiation of clinical development for bristol-myers squibb’s first collaboration product candidate appeared first on NASDAQ.